Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Guest Editorial
Imaging Brain Chemistry and Function in Neuropsychiatric Disorders
Peter C Williamson
PDF

In Review
In vivo Magnetic Resonance Spectroscopy and Its Application to Neuropsychiatric Disorders
Jeffrey A Stanley
PDF

Studies of Altered Social Cognition in Neuropsychiatric Disorders Using Functional Neuroimaging
Cheryl L Grady, Michelle L Keightley

PDF

Review Papers
Attention-Deficit Hyperactivity Disorder: Critical Appraisal of Extended Treatment Studies

Russell Schachar, Alejandro R Jadad, Mary Gauld, Michael Boyle, Lynda Booker, Anne Snider, Marie Kim, Charles Cunningham

PDF

Clinical Implications of a Link Between Fetal Alcohol Spectrum Disorder and Attention-Deficit Hyperactivity Disorder
Kieran D O'Malley, Jo Nanson

PDF

Original Research
Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment

Dennis Wardman, Nadia Khan, Nady el-Guebaly

PDF

The Impact of Latitude on the Prevalence of Seasonal Depression
Anthony J Levitt, Michael H Boyle

PDF

Preliminary Assessment of Intrahemispheric QEEG Measures in Bipolar Mood Disorders
OJ Oluboka, SL Stewart, V Sharma, D Mazmanian, E Persad

PDF

Brief Communciation
Hepatic Adverse Reactions Associated With Nefazodone
Donna E Stewart

PDF


Book Reviews
(PDF - all reviews)

Functional Neuroimaging in Child Psychiatry

Handbook of Cultural Psychiatry

The Empathetic Healer: An Endangered Species?

Cognitive Rehabilitiation: An Integrative Neuropsychological Approach

The Madness of Adam and Eve: How Schizophrenia Shaped Humanity


Letters to the Editor
(PDF - all letters)

Evidence-Based Psychiatry

Evidence-Based Psychiatry: Response

Research Ethics and Forensic Psychiatry: A Comment on Regehr and Others

Research Ethics and Forensic Psychiatry: Response

Repetitive Transcranial Magnetic Stimulation is Useful for Maintenance Treatment

The Mood Disorder Questionnaire for Assessing Bipolar Spectrum Disorder Frequency

Capgras Syndrome and Blindness: Against the Prosopagnosia Hypothesis

Re: New Centry: Overcoming Stigma, Respecting Differences—Dr Myers' Superlative Presidential Address

Steroid-Induced Psychosis Treated With Risperidone

Original Research

Prescription Medication Use Among an Aboriginal Population Accessing Addiction Treatment

Dennis Wardman, MD, FRCPC1, Nadia Khan, MD, FRCPC2, Nady el-Guebaly, MD, FRCPC3

 

Objectives: Inappropriate prescription medication use can have significant consequences. Although it is suspected that Aboriginal populations within Canada have high rates of inappropriate use, published information is lacking. To better understand this issue, we studied an Aboriginal population seeking addiction treatment.

Methods: We surveyed Aboriginal clients who accessed addiction treatment in Calgary, Alberta, for prescription medication use in the previous year, frequency of medication use, and medication source(s), if inappropriately used.

Results: Sixty-nine percent of the clients completed the survey (n = 144). Most respondents were aged 31 to 50 years (56%), and 52% were male. Of the respondents, 48% reported that they used prescription medication inappropriately, 8% indicated appropriate use, and the rest indicated no medication use. Sedatives or relaxants were most frequently used inappropriately. Among those who inappropriately used medication, 47% used medication more than 10 times in the previous year. Common sources for those who used medication inappropriately included medication given by a friend or a stranger (52%), medication bought on the street (45%), and medication prescribed by a physician (41%). Age greater than or equal to 30 years was associated with inappropriate use. Sex, residence, and Aboriginal status were not found to be associated with inappropriate use.

Conclusion: Inappropriate prescription medication use was a significant problem among an Aboriginal population that sought addiction treatment, and many of these individuals accessed medication from a prescribing physician.

(Can J Psychiatry 2002;47:355–360)

Clinical Implications

  • Our results imply a need for culturally sensitive screening, together with appropriate screening and treatments.

Limitations

  • The sample size was limited.
  • There was no non-Aboriginal comparison group.
  • Medication use may have been underestimated due to social response bias.

Key Words: Aboriginal, Native, First Nations, prescription medication, inappropriate use

Résumé : Utilisation des médicaments sur ordonnance au sein d’une population autochtone ayant accès au traitement de la toxicomanie


In 1990, an estimated 3 million people in the US used psychotherapeutic agents for nonmedical purposes. Inappropriate use of prescription medication, or its use for purposes other than intended by a prescribing physician, can have significant physical, psychological, and social consequences. In particular, Health Canada has targeted prescription drug misuse among First Nations people—those persons with special rights that date back to the signing of the number treaties in Canada—as a serious health problem (1). Despite the significant morbidity associated with inappropriate use of prescription medicine, there is little information on drug-use patterns among Aboriginal populations (that is, First Nations or status Indians, nonstatus Indians, Metis, and Inuit) (2).

Existing literature on prescription medication research has several limitations. Anderson and McEwan (2) analyzed a pharmacy claims database for the status Aboriginal population entitled to a medication subsidy. They found that 1.2% of this population excessively used acetaminophen with codeine, and up to 7.2% excessively used benzodiazepines. Excessive use was defined as greater than the maximum dosage stated by the Saskatchewan Joint Committee on Drug Use (3). The Aboriginal population also filled more prescriptions for acetaminophen with codeine and benzodiazepines than did the Canadian general population, but fewer than income-assisted clients in British Columbia. Although this study identifies a group that is at potentially high risk for inappropriate use of prescription medication—those with medication subsidization—it has limitations. For example, excessive use does not necessarily reflect inappropriate use: some medical conditions associated with chronic pain may legitimately require greater amounts of analgesia. On the other hand, pharmacy claims may underestimate inappropriate use of prescription medication, because medication can be obtained apart from a prescription.

In populations with addictions, 28% of a non-Aboriginal population seeking addiction treatment with the Alberta Alcohol and Drug Abuse Commission (AADAC) used prescription medication in the past year (unpublished data, 1998). However, AADAC data do not differentiate between appropriate and inappropriate use. Within the AADAC population, male subjects (66%) and those aged 31 to 50 years (58%) were more likely to use prescription medication. AADAC services are similar to those services offered by Native Addiction Services (NAS), where we obtained our study sample; both populations originate from the same geographical area. Therefore, a comparison with our study findings is possible. No prescription medication studies of an Aboriginal population with addiction were identified.

Several variables of interest other than age and sex may be associated with inappropriate use. As mentioned, Aboriginal status may facilitate inappropriate use arising from medication subsidies. As well, living on- or off-reserve may be important. For example, living on-reserve may facilitate social support and culturally appropriate services, but at the same time it may entail lack of opportunities for employment and education. Both lack of social support and lower income and education level have been found to be associated with addictive disorders (4).

This study aimed to determine the patterns of prescription medication use in a high-risk population: Aboriginal persons seeking addiction treatment. Specifically, we used a cross- sectional survey to investigate the prevalence of inappropriate use of stimulants, sedatives or relaxants, opioids or analgesics, and other prescription medications. This descriptive study also aimed to further characterize prescription drug use by identifying the source of the prescription medication and the frequency of its inappropriate use.


Methods

From May 15 to December 15, 2000, during their initial assessment, we gave a self-administered questionnaire to 209 new clients of the Native Addiction Services (NAS) in Calgary, Alberta. We excluded clients from the analysis if they identified themselves as non-Aboriginal. Non-Aboriginal clients were not used as a comparison group because they generally constitute too small a proportion of those who attend NAS.

 

The survey was created de novo and then pretested for cultural sensitivity, face validity, and comprehension by an Aboriginal focus group of 20 clients who accessed addiction treatment and 10 addiction-treatment service staff. The survey collected baseline demographic information, the reason for seeking treatment, and the frequency of medication use within the past year; as noted above, stimulants, sedatives or relaxants, opioids or analgesics, and other prescription medications were measured. These are the particular medication classes most commonly used inappropriately (5–7). To determine whether prescription medications were inappropriately used, patients were asked to indicate whether in the past year they had taken any of the listed medications longer, in larger amounts, or for other purposes than intended by a prescribing physician(s). Those who reported inappropriate use were then asked to indicate the source of their drug, with the following options: prescribed by a physician, prescribed by several physicians, given by a family member, taken without permission from a family member, given by a friend or a stranger, taken without permission from a friend or a stranger, bought on the street, or obtained from another source not listed.

Self-identified Aboriginal participants accessed treatment at NAS in Calgary for a period of 6 months. We obtained informed consent, participation was voluntary, and the survey was self-administered at the initial assessment. Clients deposited the completed survey into a secured box accessed only by the researchers. Surveys were anonymous, and NAS staff were not informed of survey information. Client treatment was not affected by study participation, which is critical for open reporting of this sensitive issue. The study received approval from the Conjoint Health Research Ethics Board at the University of Calgary. NAS does not collect client demographic information, and thus nonresponder information was not available.

We used STATA 7.0 statistical software to calculate the prevalence of appropriate and inappropriate use, odds ratios (ORs), confidence intervals (CIs), and 2-sided Fisher’s exact test with a P-value of 0.05 for statistical significance. Aboriginal clients who did not use prescription medication served as the comparison group.


Results

There were 149 completed surveys; 5 respondents were excluded because they self-reported non-Aboriginal descent, giving a final response rate of 69%. Most respondents were aged 31 to 50 years (56%), and 48% were women. Almost all respondents lived off reserves, and 83% classified themselves as status Indian. Alcohol abuse and illicit drug use was the most common reason for seeking treatment at NAS. Table 1 contains demographic information for all respondents, categorized by pattern of prescription medication use.

Among the respondents, 44% (n = 64) indicated that they did not use prescription medications; 8% (n = 11) reported appropriate use; and 48% (n = 69) reported inappropriate use (see Figure 1). Among those who reported inappropriate use, 58% (n = 40) used stimulants; 74% (n = 51) used sedatives or relaxants; 62% (n = 43) used opioids or analgesics; and 22% (n = 15) used other medications (see Figure 2). No participant specified the “other” prescription medication. Polypharmacy was common: 36% (n = 25) used only 1 medication class, 26% (n = 18) used 2 medication classes, 20% (n = 14) used 3 medication classes, and 17% (n = 12) used 4 medication classes. Among those who used medication appropriately, 18% (n = 2) used stimulants; 27% (n = 3) used sedatives or relaxants; and 45% (n = 5) used opioids or analgesics. Table 2 includes frequency of self-reported appropriate and inappropriate drug use. Among those who used inappropriately, 47% (n = 51) used “greater than 10 times” in the last year. As seen in Table 3, medications used inappropriately were obtained from a friend or a stranger (52%), or bought on the street (45%), or prescribed by a physician (41%).